Shopping Cart 0
Cart Subtotal
USD 0

Meridian Bioscience Inc (VIVO) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for viral, gastrointestinal, respiratory and parasitic infectious disease indications. It also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufacturing. The company develops proteins and other biological materials for use in biotechnology research for new drugs and vaccines. Meridian offers its products to acute care hospitals, outpatient clinics, reference laboratories and physician office laboratories in several countries worldwide. The company has presence in the US, Europe, Africa and the Middle East through direct offices and subsidiaries. Meridian is headquartered in Cincinnati, Ohio, the US.

Meridian Bioscience Inc (VIVO)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Meridian Bioscience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Meridian Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Meridian Bioscience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Meridian Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Meridian Bioscience Inc, Medical Equipment, Deal Details 11

Private Equity 11

Telegraph Hill Partners Acquires Dynex Technologies 11

Partnerships 12

Meridian Bioscience Enters into Licensing Agreement with University of Tennessee for Electrokinetic Sensor Technology 12

Magellan Diagnostics Enters into Distribution Agreement with Biofirm Technologies 13

Microbix Biosystems Enters into Distribution Agreement with Meridian Life Science 14

Magellan Diagnostics Enters into Distribution Agreement with MedCaptain Medical Technology 15

Biohit Enters Into Distribution Agreement With Dynex Technologies 16

Equity Offering 17

Meridian Bioscience Plans to Raise USD100 Million in Public Offering of Securities 17

Acquisition 18

Meridian Bioscience Acquires Magellan Diagnostics for USD66 Million 18

Meridian Bioscience Acquires Minority Stake in Oasis Diagnostics 20

Meridian Bioscience Inc-Key Competitors 21

Meridian Bioscience Inc-Key Employees 22

Meridian Bioscience Inc-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 25

Strategy And Business Planning 25

Jul 20, 2017: Meridian Announces Wholly Foreign Owned Enterprise Office in Beijing, China 25

Financial Announcements 26

Jul 31, 2018: Meridian Bioscience reports third quarter 2018 operating results, declares regular third quarter cash dividend, and reaffirms fiscal 2018 guidance 26

Apr 26, 2018: Meridian Bioscience Reports Second Quarter 2018 Operating Results, Declares Regular Second Quarter Cash Dividend, and Updates Fiscal 2018 Guidance 28

Jan 25, 2018: Meridian Bioscience Reports Net Revenue Of USD 52.3 Million In Q1 fiscal 2018 30

Nov 09, 2017: Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Fourth Quarter Cash Dividend, Sets Fiscal 2018 Cash Dividend Rate, and Reaffirms Fiscal 2018 Guidance 33

Oct 19, 2017: Meridian Bioscience Comments on Preliminary Fiscal 2017 Operating Results and Provides Fiscal 2018 Revenue and Earnings Guidance 35

Jul 27, 2017: Meridian Bioscience Reports Third Fiscal Quarter 2017 Operating Results 37

Apr 27, 2017: Meridian Bioscience Reports Second Quarter 2017 Operating Results 40

Apr 27, 2017: Meridian Bioscience Reports Second Quarter 2017 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2017 Guidance 42

Jan 25, 2017: Meridian Bioscience Reports First Quarter 2017 Operating Results, Reduces Regular Cash Dividend, and Revises Fiscal 2017 Guidance Downward 44

Corporate Communications 46

Sep 24, 2018: Meridian Bioscience announces retirement of John A. Kraeutler, executive chairman of the board; appoints David C. Phillips as chairman of the board; and elects Felicia Williams to the board of directors 46

Oct 10, 2017: Meridian Bioscience Appoints Jack Kenny as Chief Executive Officer 47

Aug 08, 2017: Meridian Bioscience Elects John Rice to the Board of Directors 48

Jul 20, 2017: Meridian Announces Wholly Foreign Owned Enterprise Office in Beijing, China 49

May 10, 2017: Meridian Bioscience Engages Korn Ferry to Conduct CEO Search as John A. Kraeutler Announces Plans to Retire 50

Legal and Regulatory 51

Oct 23, 2017: Meridian Bioscience Comments on FDA Press Statement Regarding Its Warning Letter Issued to Magellan Diagnostics 51

Jul 13, 2017: Meridian Bioscience Comments on Recent FDA Press Statement 52

Government and Public Interest 53

Jun 06, 2017: Meridian Bioscience Comments on Recent FDA Posting Related to Magellan Diagnostics 53

Product News 54

Aug 02, 2017: Bioline Launches New JetSeq Clean Kit for Next-Generation Sequencing 54

Mar 27, 2017: Bioline Launches New JetSeq DNA Quantification Kits 55

Feb 08, 2017: Bioline Launches New JetSeq DNA Library Preparation Kits 56

Feb 03, 2017: Meridian Bioscience Announces the Launch of TruQuick Rapid Tests for Asia Pacific 57

Jan 09, 2017: Bioline Launches the Full Range of EPIK miRNA Assays 58

Other Significant Developments 59

Mar 21, 2018: Meridian Bioscience Realigns Organizational Structure 59

Jun 30, 2017: Meridian Bioscience Comments on Recent FDA Matters Related to Magellan Diagnostics 60

Appendix 61

Methodology 61

About GlobalData 61

Contact Us 61

Disclaimer 61


List Of Figure

List of Figures

Meridian Bioscience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Meridian Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Meridian Bioscience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Meridian Bioscience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Meridian Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Meridian Bioscience Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Meridian Bioscience Inc, Medical Equipment, Key Facts, 2017 2

Meridian Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Meridian Bioscience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Meridian Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Meridian Bioscience Inc, Deals By Market, 2012 to YTD 2018 9

Meridian Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Telegraph Hill Partners Acquires Dynex Technologies 11

Meridian Bioscience Enters into Licensing Agreement with University of Tennessee for Electrokinetic Sensor Technology 12

Magellan Diagnostics Enters into Distribution Agreement with Biofirm Technologies 13

Microbix Biosystems Enters into Distribution Agreement with Meridian Life Science 14

Magellan Diagnostics Enters into Distribution Agreement with MedCaptain Medical Technology 15

Biohit Enters Into Distribution Agreement With Dynex Technologies 16

Meridian Bioscience Plans to Raise USD100 Million in Public Offering of Securities 17

Meridian Bioscience Acquires Magellan Diagnostics for USD66 Million 18

Meridian Bioscience Acquires Minority Stake in Oasis Diagnostics 20

Meridian Bioscience Inc, Key Competitors 21

Meridian Bioscience Inc, Key Employees 22

Meridian Bioscience Inc, Subsidiaries 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Meridian Bioscience Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.